Business Description
Huakang Biomedical Holdings Co Ltd
ISIN : KYG4644W1069
Compare
Compare
Traded in other countries / regions
08622.Hong Kong IPO Date
2018-12-13Description
Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagents; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and overseas.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.93 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.8 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 4.32 | |||||
| Beneish M-Score | -3.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 33.7 | |||||
| 3-Year EPS without NRI Growth Rate | 24.6 | |||||
| 3-Year FCF Growth Rate | 39.4 | |||||
| 3-Year Book Growth Rate | -10.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.1 | |||||
| 9-Day RSI | 45.63 | |||||
| 14-Day RSI | 46.03 | |||||
| 6-1 Month Momentum % | 63.27 | |||||
| 12-1 Month Momentum % | 72.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.82 | |||||
| Quick Ratio | 5.51 | |||||
| Cash Ratio | 3.79 | |||||
| Days Inventory | 139.04 | |||||
| Days Sales Outstanding | 146.03 | |||||
| Days Payable | 35.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | -4.68 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.36 | |||||
| Operating Margin % | -27.22 | |||||
| Net Margin % | -23.37 | |||||
| FCF Margin % | -6.27 | |||||
| ROE % | -10.75 | |||||
| ROA % | -8.89 | |||||
| ROIC % | -25.99 | |||||
| ROC (Joel Greenblatt) % | -36.59 | |||||
| ROCE % | -10.53 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.31 | |||||
| PB Ratio | 1.25 | |||||
| Price-to-Tangible-Book | 1.25 | |||||
| EV-to-EBIT | -10.87 | |||||
| EV-to-EBITDA | -10.87 | |||||
| EV-to-Revenue | 2.51 | |||||
| EV-to-FCF | -40.13 | |||||
| Price-to-Projected-FCF | 7.5 | |||||
| Price-to-Net-Current-Asset-Value | 1.5 | |||||
| Price-to-Net-Cash | 2.5 | |||||
| Earnings Yield (Greenblatt) % | -9.2 | |||||
| FCF Yield % | -2.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Huakang Biomedical Holdings Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 27.067 | ||
| EPS (TTM) (HK$) | -0.016 | ||
| Beta | 0.04 | ||
| Volatility % | 75.97 | ||
| 14-Day RSI | 46.03 | ||
| 14-Day ATR (HK$) | 0.017623 | ||
| 20-Day SMA (HK$) | 0.1492 | ||
| 12-1 Month Momentum % | 72.04 | ||
| 52-Week Range (HK$) | 0.08 - 0.247 | ||
| Shares Outstanding (Mil) | 500.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Huakang Biomedical Holdings Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Huakang Biomedical Holdings Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Huakang Biomedical Holdings Co Ltd Frequently Asked Questions
What is Huakang Biomedical Holdings Co Ltd(HKSE:08622)'s stock price today?
The current price of HKSE:08622 is HK$0.15. The 52 week high of HKSE:08622 is HK$0.25 and 52 week low is HK$0.08.
When is next earnings date of Huakang Biomedical Holdings Co Ltd(HKSE:08622)?
The next earnings date of Huakang Biomedical Holdings Co Ltd(HKSE:08622) is .
Does Huakang Biomedical Holdings Co Ltd(HKSE:08622) pay dividends? If so, how much?
Huakang Biomedical Holdings Co Ltd(HKSE:08622) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers